These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 28127652)
1. The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. Ruel E; Thomas S; Perkins JM; Roman SA; Sosa JA Ann Surg Oncol; 2017 Jul; 24(7):1935-1942. PubMed ID: 28127652 [TBL] [Abstract][Full Text] [Related]
2. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045 [TBL] [Abstract][Full Text] [Related]
3. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study. Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406 [TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma. Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850 [TBL] [Abstract][Full Text] [Related]
5. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer. Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211 [TBL] [Abstract][Full Text] [Related]
6. Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection. Deutschmann MW; Chin-Lenn L; Nakoneshny SC; Dort JC; Pasieka JL; Chandarana SP J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):55. PubMed ID: 27793192 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma. Yang Z; Flores J; Katz S; Nathan CA; Mehta V Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752 [TBL] [Abstract][Full Text] [Related]
9. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. Zevallos JP; Xu L; Yiu Y Thyroid; 2014 Apr; 24(4):758-63. PubMed ID: 24378070 [TBL] [Abstract][Full Text] [Related]
10. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy? Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002 [TBL] [Abstract][Full Text] [Related]
11. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA. Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study. Kwon SY; Kim MH; Kong E; Chong A; Yoo SW; Jeon S; Park SA; Kim DW; Kang SH; Choi JE; Ha JM; Jeong SY; Lee SW Clin Endocrinol (Oxf); 2021 Dec; 95(6):901-908. PubMed ID: 34185324 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816 [TBL] [Abstract][Full Text] [Related]
14. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy? Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181 [TBL] [Abstract][Full Text] [Related]
15. Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma. Suman P; Wang CH; Moo-Young TA; Prinz RA; Winchester DJ Am Surg; 2016 Sep; 82(9):807-14. PubMed ID: 27670568 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer. Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118 [TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma. Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Vassilopoulou-Sellin R; Schultz PN; Haynie TP Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396 [TBL] [Abstract][Full Text] [Related]
19. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer. Wang LY; Palmer FL; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I Ann Surg Oncol; 2015 Oct; 22(11):3530-6. PubMed ID: 25665952 [TBL] [Abstract][Full Text] [Related]
20. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection. Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]